// App-Quantinova.ai

: INOTUZUMAB OZAGAMICIN IS SAFE AND EFFECTIVE IN RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE ITALIAN CENTER EXPERIENCE

Researchers

Presenter

  • Chiara Sartor

Principal Investigators

  • Giovanni Marconi

  • Maria Chiara Abbenante

  • Valentina Robustelli

  • Carmen Baldazzi

  • Gianluca Cristiano

  • Jacopo Nanni

  • Sarah Parisi

  • Carolina Terragna

  • Nicoletta Testoni

  • Simona Soverini

  • Giovanni Martinelli

  • Stefania Paolini

  • Antonio Curti

  • Michele Cavo

  • Cristina Papayannidis

Medical Centers

  • Azienda Ospedaliero Universitaria S.Orsola Malpighi Bologna, Istituto di Ematologia,bologna,Italy

  • UOC di Ematologia, Casa di Cura Sollievo della Sofferenza, San Giovanni Rotondo.,San Giovanni Rotondo,Italy

  • Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • T-cell receptor

Drug/Treatment

  • Inotuzumab ozogamicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved